ethosuximide has been researched along with Scleroderma, Localized in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Scleroderma, Localized: A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyama, T | 1 |
| Asano, Y | 1 |
| Taniguchi, T | 1 |
| Takahashi, T | 1 |
| Ichimura, Y | 1 |
| Tamaki, Z | 1 |
| Kagami, S | 1 |
| Mitsui, H | 1 |
| Sato, S | 1 |
1 other study available for ethosuximide and Scleroderma, Localized
| Article | Year |
|---|---|
Ethosuximide-induced lupus-scleroderma syndrome with disease-specific autoantibodies.
Topics: Anticonvulsants; Autoantibodies; Child; Ethosuximide; Female; Humans; Lupus Erythematosus, Systemic; | 2017 |